同时使用多种毒素,包括脏低输液药物,导致毒素相关的毒性:对两个现实世界数据库的综合回顾分析
Takashi Bando1,2, Masayuki Chuma3,4, Hirofumi Hamano2,5
1Department of Pharmacy, Tokushima University Hospital.
Acta medica Okayama
|December 25, 2023
概括
同时使用毒素会增加与万科米辛相关的毒性 (VAN) 的风险. 与多种毒素,特别是那些影响脏血流的毒素结合使用,显著提高了VAN的发生率.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 临床医学 临床医学
背景情况:
- 范科米辛相关性毒性 (VAN) 是一个重要的临床问题.
- 同时使用毒素对VAN风险的影响需要进一步阐明.
研究的目的:
- 为了研究同时使用毒素和与菌素相关的毒性之间的关系.
- 为了确定加剧VAN风险的特定毒素组合.
主要方法:
- 对FDA不良事件报告系统 (FAERS) 数据库的回顾性分析.
- 通过东岛大学医院的电子病历 (EMR) 进行验证 (2006-2019).
- 对报告VAN发病率的概率比率 (ROR) 和概率比率 (OR) 的评估.
主要成果:
- FAERS数据显示,VAN的ROR增加,同时出现的毒素数量增加.
- 电子回路分析证实了毒素数量与更高的VAN发病率 (OR:1.99) 之间存在显著的关联.
- 当脏低 perfusion 药物 (furosemide,NSAID,血管压缩剂) 同时使用时,VAN 风险特别增加.
结论:
- 同时使用毒素显著增加了毒素相关毒性的发生率.
- 避免多种毒素,特别是导致脏低的毒素,对于预防VAN至关重要.
- 这一发现对接受Vancomycin的患者的药物管理有影响.
相关概念视频
Heart Failure Drugs: Diuretics
394
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
394
Renal Failure: Dose Adjustments
94
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
94
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Drug Elimination by Renal Route: Tubular Secretion
2.4K
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
2.4K
Heart Failure Drugs: Inotropic Agents
594
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
594


